Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy
Titel:
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy
Auteur:
Wagner, Nikolaus B. Lenders, Max M. Kühl, Kathrin Reinhardt, Lydia Fuchß, Milena Ring, Natalie Stäger, Ramon Zellweger, Caroline Ebel, Chiara Kimeswenger, Susanne Oellinger, Angela Amaral, Teresa Forschner, Andrea Leiter, Ulrike Klumpp, Bernhard Hoetzenecker, Wolfram Terheyden, Patrick Mangana, Joanna Loquai, Carmen Cozzio, Antonio Garbe, Claus Meier, Friedegund Eigentler, Thomas K. Flatz, Lukas